Here's the latest news from Santéand its portfolio companies
Portfolio
Glyscend Therapeutics Announces Positive Topline Phase 2a Clinical Results and Progress with GLY-200, a First-in-Class Treatment for Type 2 Diabetes and Obesity
May 31, 2023
Portfolio
ABK Biomedical Announces FDA IDE Approval for a Multi-Center Pivotal Study of Eye90 microspheres(R) in Hepatocellular Carcinoma
May 31, 2023
Portfolio
BeeKeeperAI Announces Commercial Release of its Patented, Zero-Trust Collaboration Platform to Accelerate Healthcare AI Development on Protected Information
May 19, 2023
Santé
Partner, Dennis McWilliams Fireside Chat: From Operator to Investor (and back); Perspectives From Wearing Both Hats | LSI USA ‘23 (Video)
May 19, 2023
Portfolio
Endogenex™ Appoints Christopher Sorli as Chief Medical Officer
May 18, 2023
Portfolio
Surgical Safety Technologies secures US $15M Series A
May 9, 2023
Portfolio
Friday Q&A: Boston Scientific’s De Rosa on the rise of an AFib ‘game changer’
May 8, 2023
Portfolio
Endogenex™ Announces Presentation of First Human Clinical Experience
May 4, 2023
Portfolio
CareHive Revolutionizes Telemedicine with Groundbreaking CareHive360 Digital Health Technology
April 26, 2023
Portfolio
Endogenex CEO Stacey Pugh Combines Bedside Background with Market Experience to Affect Change for Type 2 Diabetes (Podcast)
April 25, 2023
Portfolio
Geneos: DNA-based, personalized cancer vaccines
April 19, 2023
Portfolio
Advocate Health’s research arm pilots KelaHealth’s predictive software to assess surgical risk, improve outcome
April 17, 2023
Portfolio
Geneos Therapeutics Secures $5 Million in Series A3 Financing
April 12, 2023
Santé
Santé Ventures and Fogarty Innovation: Kindred Spirits
March 29, 2023
Portfolio
Endogenex taps former Medtronic executive as CEO
March 27, 2023
Santé
VC firm using SXSW to highlight Austin’s health care bonafides
